The Brighterside of News on MSN
Scientists found the genetic switch that makes primary cilia grow
Primary cilia play a powerful role in how cells sense their surroundings. They help guide embryo development and ensure organs grow in the right place. If they don’t form properly, the results can be ...
Studies show 3 in 10,000 people develop heart cancer. In comparison, 1 in 20 women are expected to develop breast cancer. Why is that?
Scientists at the University of North Texas report a breakthrough in building tiny, lab-grown replicas of human organs.
In 2017, Ashley Moffett, a reproductive immunologist, walked to the pharmacy near her laboratory at the University of ...
News Medical on MSN
Good vibrations could revolutionize assisted reproductive technology, reveals research
In the quest to address infertility, Cornell University researchers have developed a groundbreaking device that could ...
While there is no known cure for the condition, doctors at Yubei District People's Hospital in China have reported how ...
Stanford Medicine researchers have developed an artificial intelligence tool to help scientists better plan gene-editing ...
Emirates News Agency on MSN
AI-driven innovation in reproductive health takes centre stage at Trust Fertility & Gynecology Conference in Abu Dhabi
As part of its mission to enhance fertility care in the region, Burjeel Holdings has commenced the Trust Fertility & Gynecology Conference 2025 in Abu Dhabi, bringing together leading international ...
Dewsbury Reporter on MSN
Dewsbury man achieves honorary 'Hafiz' title after overcoming dyslexia to memorise the entire Koran
A Dewsbury man has achieved another important milestone in his life - this time by learning to memorise the entire Koran off ...
The Times of Israel on MSN
Zebrafish help Israeli researchers hook potential cure for deadly genetic disease
Scientists from Weizmann Institute and Sheba Medical Center says they were able to recreate rare lymphatic illness KLA in aquatic creatures, and treat it; they hope humans come next ...
The Company has submitted a supplemental New Drug Application (sNDA) seeking the approval of revumenib for the treatment of R/R mNPM1 AML. The sNDA has been granted Priority Review by the FDA and ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results